Literature DB >> 16807713

Mitochondrial DNA sequence variation and mutation rate in patients with CADASIL.

Johanna Annunen-Rasila1, Saara Finnilä, Kati Mykkänen, Jukka S Moilanen, Johanna Veijola, Minna Pöyhönen, Matti Viitanen, Hannu Kalimo, Kari Majamaa.   

Abstract

Mutations in the NOTCH3 gene cause cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), which is clinically characterised by recurrent ischemic strokes, migraine with aura, psychiatric symptoms, cognitive decline and dementia. We have previously described a patient with CADASIL caused by a R133C mutation in the NOTCH3 gene and with a concomitant myopathy caused by a 5650G>A mutation in the MTTA gene in mitochondrial DNA (mtDNA). We assume that the co-occurrence of the two mutations is not coincidental and that mutations in the NOTCH3 gene may predispose the mtDNA to mutations. We therefore examined the nucleotide variation in the mtDNA coding region sequences in 20 CADASIL pedigrees with 77 affected patients by conformation-sensitive gel electrophoresis and sequencing. The sequence variation in mtDNA was then compared with that among 192 healthy Finns. A total of 180 mtDNA coding region sequence differences were found relative to the revised Cambridge reference sequence, including five novel synonymous substitutions, two novel nonsynonymous substitutions and one novel tRNA substitution. We found that maternal relatives in two pedigrees differed from each other in their mtDNA. Furthermore, the average number of pairwise differences in sequences from the 41 unrelated maternal lineages with CADASIL was higher than that expected among haplogroup-matched controls. The numbers of polymorphic sites and polymorphisms that were present in only one sequence were also higher among the CADASIL sequences than among the control sequences. Our results show that mtDNA sequence variation is increased within CADASIL pedigrees. These findings suggest a relationship between NOTCH3 and mtDNA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16807713     DOI: 10.1007/s10048-006-0049-x

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  45 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  The mutation rate in the human mtDNA control region.

Authors:  S Sigurğardóttir; A Helgason; J R Gulcher; K Stefansson; P Donnelly
Journal:  Am J Hum Genet       Date:  2000-04-07       Impact factor: 11.025

3.  On the number of segregating sites in genetical models without recombination.

Authors:  G A Watterson
Journal:  Theor Popul Biol       Date:  1975-04       Impact factor: 1.570

Review 4.  Mitochondrial respiratory-chain diseases.

Authors:  Salvatore DiMauro; Eric A Schon
Journal:  N Engl J Med       Date:  2003-06-26       Impact factor: 91.245

5.  A novel mitochondrial DNA mutation and a mutation in the Notch3 gene in a patient with myopathy and CADASIL.

Authors:  S Finnilä; S Tuisku; R Herva; K Majamaa
Journal:  J Mol Med (Berl)       Date:  2001-11       Impact factor: 4.599

6.  Testing heterozygote excess and deficiency.

Authors:  F Rousset; M Raymond
Journal:  Genetics       Date:  1995-08       Impact factor: 4.562

7.  Statistical tests of neutrality of mutations.

Authors:  Y X Fu; W H Li
Journal:  Genetics       Date:  1993-03       Impact factor: 4.562

8.  Recombination of mitochondrial DNA in skeletal muscle of individuals with multiple mitochondrial DNA heteroplasmy.

Authors:  Gábor Zsurka; Yevgenia Kraytsberg; Tatiana Kudina; Cornelia Kornblum; Christian E Elger; Konstantin Khrapko; Wolfram S Kunz
Journal:  Nat Genet       Date:  2005-07-17       Impact factor: 38.330

9.  A novel NOTCH3 frameshift deletion and mitochondrial abnormalities in a patient with CADASIL.

Authors:  Maria Teresa Dotti; Nicola De Stefano; Silvia Bianchi; Alessandro Malandrini; Carla Battisti; Elena Cardaioli; Antonio Federico
Journal:  Arch Neurol       Date:  2004-06

10.  Clinical spectrum of CADASIL: a study of 7 families. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.

Authors:  H Chabriat; K Vahedi; M T Iba-Zizen; A Joutel; A Nibbio; T G Nagy; M O Krebs; J Julien; B Dubois; X Ducrocq
Journal:  Lancet       Date:  1995-10-07       Impact factor: 79.321

View more
  9 in total

1.  Non-convulsive status epilepticus causing focal neurological deficits in CADASIL.

Authors:  Philipp O Valko; Massimiliano M Siccoli; Andreas Schiller; Heinz-Gregor Wieser; Hans H Jung
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-11       Impact factor: 10.154

2.  mtDNA data mining in GenBank needs surveying.

Authors:  Yong-Gang Yao; Antonio Salas; Ian Logan; Hans-Jürgen Bandelt
Journal:  Am J Hum Genet       Date:  2009-12       Impact factor: 11.025

3.  Non-convulsive status epilepticus causing focal neurological deficits in CADASIL.

Authors:  Philipp O Valko; Massimiliano M Siccoli; Andreas Schiller; Heinz G Wieser; Hans H Jung
Journal:  BMJ Case Rep       Date:  2009-01-23

4.  Non-convulsive status epilepticus causing focal neurological deficits in CADASIL.

Authors:  Philipp O Valko; Massimiliano M Siccoli; Andreas Schiller; Heinz G Wieser; Hans H Jung
Journal:  BMJ Case Rep       Date:  2009-02-02

5.  Nerve conduction studies in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.

Authors:  Sa-Yoon Kang; Jung-Hwan Oh; Ji-Hoon Kang; Jay Chol Choi; Jung Seok Lee
Journal:  J Neurol       Date:  2009-06-02       Impact factor: 4.849

6.  Proteome analysis of cultivated vascular smooth muscle cells from a CADASIL patient.

Authors:  Saara Ihalainen; Rabah Soliymani; Erika Iivanainen; Kati Mykkänen; Annele Sainio; Minna Pöyhönen; Klaus Elenius; Hannu Järveläinen; Matti Viitanen; Hannu Kalimo; Marc Baumann
Journal:  Mol Med       Date:  2007 May-Jun       Impact factor: 6.354

7.  Mitochondrial DNA haplogroups M7b1'2 and M8a affect clinical expression of leber hereditary optic neuropathy in Chinese families with the m.11778G-->a mutation.

Authors:  Yanli Ji; A-Mei Zhang; Xiaoyun Jia; Ya-Ping Zhang; Xueshan Xiao; Shiqiang Li; Xiangming Guo; Hans-Jürgen Bandelt; Qingjiong Zhang; Yong-Gang Yao
Journal:  Am J Hum Genet       Date:  2008-11-20       Impact factor: 11.025

8.  What can a comparative genomics approach tell us about the pathogenicity of mtDNA mutations in human populations?

Authors:  Hannah O'Keefe; Rachel Queen; Phillip Lord; Joanna L Elson
Journal:  Evol Appl       Date:  2019-08-27       Impact factor: 5.183

9.  Absence of mtDNA mutations in leukocytes of CADASIL patients.

Authors:  Khaled K Abu-Amero; Ali Hellani; Saeed Bohlega
Journal:  BMC Res Notes       Date:  2008-05-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.